Literature DB >> 2926418

Visual contrast sensitivity in drug-induced Parkinsonism.

C Bulens1, J D Meerwaldt, G J van der Wildt, C J Keemink.   

Abstract

The influence of stimulus orientation on contrast sensitivity function was studied in 10 patients with drug-induced Parkinsonism. Nine of the 10 patients had at least one eye with contrast sensitivity deficit for vertical and/or horizontal stimuli. Only generalised contrast sensitivity loss, observed in two eyes, was stimulus orientation independent. All spatial frequency-selective contrast deficits in 15 eyes were orientation dependent. The striking similarity between the pattern of contrast sensitivity loss in drug-induced Parkinsonism and that in idiopathic Parkinson's disease, suggests that generalised dopaminergic deficiency, from whatever cause, affects visual function in an analogous way.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2926418      PMCID: PMC1032408          DOI: 10.1136/jnnp.52.3.341

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  Effect of stimulus orientation on contrast sensitivity in Parkinson's disease.

Authors:  C Bulens; J D Meerwaldt; G J Van der Wildt
Journal:  Neurology       Date:  1988-01       Impact factor: 9.910

2.  Effect of levodopa treatment on contrast sensitivity in Parkinson's disease.

Authors:  C Bulens; J D Meerwaldt; G J Van der Wildt; J B Van Deursen
Journal:  Ann Neurol       Date:  1987-09       Impact factor: 10.422

3.  Contrast sensitivity in Parkinson's disease.

Authors:  C Bulens; J D Meerwaldt; G J van der Wildt; C J Keemink
Journal:  Neurology       Date:  1986-08       Impact factor: 9.910

4.  Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders.

Authors:  T N Chase; J A Schnur; E K Gordon
Journal:  Neuropharmacology       Date:  1970-05       Impact factor: 5.250

5.  Orientation-selective visual loss in patients with Parkinson's disease.

Authors:  D Regan; C Maxner
Journal:  Brain       Date:  1987-04       Impact factor: 13.501

6.  Measurements of visual evoked potentials in Parkinson's disease.

Authors:  I Bodis-Wollner; M D Yahr
Journal:  Brain       Date:  1978-12       Impact factor: 13.501

7.  Uptake and efflux of 14-C-dopamine in platelets: evidence for a generalized defect in Parkinson's disease.

Authors:  A Barbeau; G Campanella; R F Butterworth; K Yamada
Journal:  Neurology       Date:  1975-01       Impact factor: 9.910

8.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

9.  Dopaminergic deficiency and delayed visual evoked potentials in humans.

Authors:  I Bodis-Wollner; M D Yahr; L Mylin; J Thornton
Journal:  Ann Neurol       Date:  1982-05       Impact factor: 10.422

10.  Receptive field properties of neurones in visual area 1 and visual area 2 in the baboon.

Authors:  H Kennedy; K A Martin; G A Orban; D Whitteridge
Journal:  Neuroscience       Date:  1985-02       Impact factor: 3.590

View more
  9 in total

1.  Spatial contrast sensitivity: effects of reliability, test-retest repeatability and sample size using the Metropsis software.

Authors:  Thiago Paiva Fernandes; Natalia Leandro de Almeida; Pamela D Butler; Natanael Antonio Santos
Journal:  Eye (Lond)       Date:  2019-06-05       Impact factor: 3.775

2.  Retinal dysfunction of contrast processing in major depression also apparent in cortical activity.

Authors:  Emanuel Bubl; Elena Kern; Dieter Ebert; Andreas Riedel; Ludger Tebartz van Elst; Michael Bach
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-01-08       Impact factor: 5.270

3.  Nicotine gum enhances visual processing in healthy nonsmokers.

Authors:  Thiago P Fernandes; Natalia L Almeida; Gabriella M Silva; Natanael A Santos
Journal:  Brain Imaging Behav       Date:  2021-03-06       Impact factor: 3.978

Review 4.  Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.

Authors:  Jee-Young Lee; Antonio Martin-Bastida; Ane Murueta-Goyena; Iñigo Gabilondo; Nicolás Cuenca; Paola Piccini; Beomseok Jeon
Journal:  Nat Rev Neurol       Date:  2022-02-17       Impact factor: 44.711

5.  Selective effects of low doses of apomorphine on spatiotemporal contrast sensitivity in healthy volunteers: a double-blind placebo-controlled study.

Authors:  O Blin; D Mestre; G Masson; G Serratrice
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

Review 6.  Dopamine: A Modulator of Circadian Rhythms in the Central Nervous System.

Authors:  Kirill S Korshunov; Laura J Blakemore; Paul Q Trombley
Journal:  Front Cell Neurosci       Date:  2017-04-03       Impact factor: 5.505

7.  Contrast Acuity With Different Colors in Parkinson's Disease.

Authors:  Harsh V Gupta; Nan Zhang; Erika Driver-Dunckley; Shyamal H Mehta; Thomas G Beach; Charles H Adler
Journal:  Mov Disord Clin Pract       Date:  2019-09-06

8.  Schizophrenia and the eye.

Authors:  Steven M Silverstein; Richard Rosen
Journal:  Schizophr Res Cogn       Date:  2015-06

9.  Schizophrenia spectrum participants have reduced visual contrast sensitivity to chromatic (red/green) and luminance (light/dark) stimuli: new insights into information processing, visual channel function, and antipsychotic effects.

Authors:  Kristin S Cadenhead; Karen Dobkins; Jessica McGovern; Kathleen Shafer
Journal:  Front Psychol       Date:  2013-08-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.